Screener
Nektar Therapeutics NKTR Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Nektar Therapeutics’s 10-Q, filed May 8, 2026.
- Filed
- May 7, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-212596
| Line item | Three Months Ended March 31, | Three Months Ended March 31, | Three Months Ended March 31, |
|---|---|---|---|
| 2026 | 2025(1) | ||
| Revenue: | |||
| Non-cash royalty revenue related to the sales of future royalties | $ | $$10,861 | 10,460 |
| Total revenue | 10,861 | 10,460 | |
| Operating costs and expenses: | |||
| Research and development (including $1,708 and $208 for the three months ended March 31, 2026 and 2025, respectively, from a related party) | 35,680 | 30,480 | |
| General and administrative | 13,439 | 24,346 | |
| Restructuring and impairment | 796 | 169 |
Item 1. Condensed Consolidated Financial Statements—Unaudited:
FAQ
- What is Nektar Therapeutics's total revenue?
- Nektar Therapeutics (NKTR) reported total revenue of $10.86M in Q1 2026.
- How has Nektar Therapeutics's total revenue changed year-over-year?
- Nektar Therapeutics's total revenue increased by 3.8% year-over-year, from $10.46M to $10.86M.
- What is the long-term trend for Nektar Therapeutics's total revenue?
- Over 4 years (2021 to 2025), Nektar Therapeutics's total revenue has grown at a -14.2% compound annual growth rate (CAGR), from $101.91M to $55.23M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Nektar Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude